Free Trial

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $2.95 Billion Holdings in Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • UBS Asset Management increased its stake in Procter & Gamble by 6.3%, now holding approximately 17.3 million shares valued at around $2.95 billion.
  • CEO Jon R. Moeller and CEO Gary A. Coombe both sold shares worth over $7.9 million combined, reflecting significant decreases in their ownership percentages.
  • Procter & Gamble recently declared a quarterly dividend of $1.0568 per share, with a dividend yield of 2.7% and a payout ratio of 64.82%.
  • MarketBeat previews the top five stocks to own by October 1st.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,293,428 shares of the company's stock after acquiring an additional 1,018,865 shares during the period. Procter & Gamble makes up approximately 0.8% of UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC's holdings, making the stock its 17th biggest holding. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.74% of Procter & Gamble worth $2,947,146,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in PG. Woodline Partners LP increased its stake in shares of Procter & Gamble by 45.5% during the first quarter. Woodline Partners LP now owns 198,105 shares of the company's stock worth $33,761,000 after purchasing an additional 61,957 shares during the period. Empowered Funds LLC lifted its holdings in Procter & Gamble by 13.4% during the 1st quarter. Empowered Funds LLC now owns 183,691 shares of the company's stock worth $31,305,000 after buying an additional 21,758 shares during the period. AAF Wealth Management LLC lifted its stake in Procter & Gamble by 10.7% in the first quarter. AAF Wealth Management LLC now owns 1,610 shares of the company's stock valued at $274,000 after buying an additional 155 shares during the period. HFM Investment Advisors LLC acquired a new position in Procter & Gamble in the first quarter valued at approximately $182,000. Finally, MBB Public Markets I LLC acquired a new position in Procter & Gamble during the 1st quarter worth approximately $307,000. 65.77% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the sale, the chief executive officer owned 319,375 shares of the company's stock, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 in the last quarter. Company insiders own 0.18% of the company's stock.

Procter & Gamble Trading Down 0.6%

PG opened at $159.12 on Tuesday. The business has a 50 day simple moving average of $156.41 and a two-hundred day simple moving average of $162.14. The firm has a market capitalization of $372.42 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 4.22 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the prior year, the business earned $1.40 EPS. The business's revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio is presently 64.82%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on PG. Barclays set a $164.00 price target on Procter & Gamble and gave the stock an "equal weight" rating in a report on Thursday, July 31st. BNP Paribas reissued an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reaffirmed an "in-line" rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Wells Fargo & Company lowered their price target on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Finally, UBS Group set a $180.00 price target on Procter & Gamble and gave the company a "buy" rating in a report on Wednesday, July 30th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and a consensus price target of $175.12.

Get Our Latest Research Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Forget Earnings Hype: 2 Must-Buy Stocks and 2 to Dump
AMD’s 2026 Forecasts Are Way Too Low
Massive Data Week Could Rock Markets — Here Are the Top Plays

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines